Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

Fresenius break up debate goes public

Giant health care conglomerate Fresenius SE has publicly floated the possibility of bringing minority equity shareholders in at the level of divisions such as Vamed or Helios in its 2021 results announcement. It has even suggested it could sell its controlling stake in dialysis arm Fresenius Medical Care. But at least one investment bank is publicly stating this doesn't go far enough.
February 25, 2022

Who is building broad outpatient businesses in Europe?

A wide range of outpatient specialities can be linked to a diagnostics and/or primary care back bone, building a complete ambulatory ecosystem linked by telehealth. Thanks to employers paying, this is a reality in Finland with Terveystalo and in Poland with Lux-Med and Medicover. Similar hub and spoke models are also the norm in the United Arab Emirates. But can it be done elsewhere and who is doing it? We name the highly ambitious operators and their platforms across the main European countries.
February 17, 2022

Korian shares drop as it faces group lawsuit

French elderly care giant Korian has been dragged into the controversy surrounding the French nursing home sector. A lawyer is launching a group lawsuit against the company based on the experiences of some of the residents at its nursing homes. HBI speaks to financial analysts to find out what the potential long term impact on the sector might be of this, and the ongoing Orpea crisis.
February 10, 2022

Fertility sector heating up with three major deals underway

The fertility sector is heating up with multiple deals underway. The UK’s largest group by revenue, CARE Fertility, has been bought for £300m by PE firm Nordic Capital; Reuters reports that of $2.2bn are currently being "lined up" for the largest international player, IVI-RMA. And Australia’s largest group, Virtus Health, is being bought by PE firm CapVest for an equity value of A$650m.
February 3, 2022

Orpea and Korian shares plummet, as book alleges malpractice at Orpea

The share prices of Europe’s two nursing home giants, Orpea and Korian, both plummeted on Monday, after extracts from a book about Orpea containing allegations of malpractice were published in French newspaper Le Monde. Orpea, whose shares have halved in value, strongly rejects the allegations.
January 27, 2022

UK fertility provider set to sell

HBI can exclusively reveal that a substantial UK-based fertility provider looks set to come to market later this year. HBI speaks to sources about possible pricing and buyers.
January 20, 2022

Genetics: the M&A drive

The big diagnostic lab groups are on a frantic M&A drive to capture capacity in genetic testing. The deals reflect the hunger for specialist genetic doctors, biologists and counsellors in a manpower intensive field which is seeing explosive growth. We look at recent deals and name the new competitors who are entering the market.
January 13, 2022

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.
December 22, 2021

Ramsay buys Elysium

International hospital operator Ramsay Healthcare is entering the UK mental health hospital market with the £775m (€907m) acquisition of Elysium Healthcare.
December 16, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us